Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0G2CY
|
||||
Former ID |
DNC009204
|
||||
Drug Name |
(+/-)-3-allylazetidin-2-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529529] | ||
Structure |
Download2D MOL |
||||
Formula |
C6H9NO
|
||||
Canonical SMILES |
C=CCC1CNC1=O
|
||||
InChI |
1S/C6H9NO/c1-2-3-5-4-7-6(5)8/h2,5H,1,3-4H2,(H,7,8)
|
||||
InChIKey |
XWLCLNCCEDQVSS-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529529] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.